Skip to main content
Journal of Microbiology and Biotechnology logoLink to Journal of Microbiology and Biotechnology
. 2023 Nov 15;34(1):141–148. doi: 10.4014/jmb.2309.09001

Effect of Resveratrol and Curcumin on Gene Expression of Methicillin-Resistant Staphylococcus aureus (MRSA) Toxins

Areej M El-Mahdy 1, Maisa Alqahtani 2, May Almukainzi 3,*, Majed F Alghoribi 4,5,6, Shaymaa H Abdel-Rhman 1,7
PMCID: PMC10840468  PMID: 37986579

Abstract

Staphylococcus aureus is an opportunistic pathogen that can lead to a number of potentially terrible community- and hospital-acquired illnesses. Among the diverse set of virulence factors that S. aureus possesses, secreted toxins play a particularly preeminent role in defining its virulence. In this work, we aimed to facilitate the development of novel strategies utilizing natural compounds to lower S. aureus’s toxin production and consequently enhance therapeutic approaches. Two natural polyphenols, resveratrol (RSV) and curcumin (CUR), were tested for their effect on reducing toxin gene production of MRSA isolates. Fifty clinical MRSA isolates were gathered from Riyadh and Jeddah. Molecular screening of toxin genes (sea, seb, sec, sed, seh, lukF, and lukS) harbored by MRSA was performed. Sub-inhibitory concentrations of RSV (50 μg/ml) and CUR (20 μg/ml) were determined to study their effect on the gene expression MRSA’s toxin genes. Our findings revealed the presence of the tested genes in MRSA isolates, with lukF being the most prevalent gene and seh the least detected gene. We found that RSV reduced the relative expression of toxin genes, sea, seb, lukF, and lukS, respectively, while CUR decreased the relative expression of sea and seb genes in the examined isolates. Regarding lukF and lukS, CUR downregulated the expression of both genes in some isolates and upregulated the expression in other isolates. From these results, we concluded that RSV and CUR could be used as alternative therapeutic approaches to treat MRSA infections through reducing toxin production.

Keywords: Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), resveratrol, curcumin, toxins, gene expression

Introduction

Staphylococcus aureus is a gram-positive opportunistic bacterium that is often found as normal flora. Sometimes it enters the body through the skin and causes both community- and hospital-acquired infections. These infections are of three categories; infections of the skin, disease through toxin production, or systemic and life-threatening conditions. Toxin-mediated and invasive infections depend mainly on strains and sites of infection [1, 2].

In particular, the widespread antibiotic resistance among S. aureus isolates makes their infection problematic. In comparison to methicillin-sensitive S. aureus (MSSA), methicillin-resistant S. aureus (MRSA) has been linked to higher rates of hospitalization and death. MRSA strains have developed resistance to other antibiotics, which limits the available treatment options [3, 4].

S. aureus has established a regulated toxin production system in which the three main classes generated are pore-forming toxins, exfoliative toxins, and superantigens. There is a distinct relationship between these toxins and some life-threatening conditions. Panton-Valentine leucocidin (PVL) is a powerful staphylococcal exotoxin that exerts its activity through two secretory proteins; types F and S. In addition to causing polymorphonuclear cells to release oxygen metabolites and lose their plasma membrane, PVL also causes lysozyme production and the release of histamine from human basophils. PVL determinants are found in the majority of S. aureus strains that cause necrotizing pneumonia and primary cutaneous infections. These toxins are found in 85% of the community-acquired MRSA strains [5]. On the other hand, PVL genes were not detected in any S. aureus strains causing endocarditis, hospital-acquired infections, toxic-shock syndrome, or urinary tract infections [6].

The second class, serine proteases known as exfoliative toxins (ETs), bind to and hydrolyze desmosome cadherins in the epidermis' outermost layers [7]. They cleave keratinocyte junctions in the epidermis of the skin leading to peeling and blistering of the skin. The principal ETs are ETA, ETB, ETC, and ETD, and these are secreted by only 5% of strains. The most common ones that cause skin injury in humans are ETA and ETB, while ETC has only been linked to infections in horses, and ETD was first discovered in a clinical sample of S. aureus in 2002 [8].

Superantigens (SAgs), formerly known as staphylococcal enterotoxins (SEs), are the third class and are the cause of food poisoning caused by S. aureus [5]. In addition to the toxic shock syndrome toxin (TSST-1) and the staphylococcal enterotoxins, there are currently 11 staphylococcal superantigen-like (SSL) toxins and 23 staphylococcal SAg toxins [9].

Numerous secondary metabolites produced by plants act as a chemical barrier against infections; therefore, it makes sense to use them as a source of prototype chemicals. Natural phenolic substances have antimicrobial properties in part because they harm bacterial membranes, prevent the production of virulence factors including enzymes and toxins, and hinder the growth of biofilms [10].

Red wine, grapes, berries, peanuts, and other foods naturally contain the phytoalexin RSV (3, 5, 4'-trihydroxy-trans-stilbene) that is also produced due to pathogen attack [11]. RSV, a polyphenolic substance, has potent anti-estrogenic, antioxidant, antiarteriosclerosis, antibacterial, and anticancer characteristics, as well as the capacity to prevent the development of hepatic fat and eicosanoids [12, 13].

Curcumin (CUR) is a natural chemical obtained from a variety of Curcuma species as it is one of the major components of turmeric roots/rhizomes (Curcuma longa L.) [12]. Studies have shown that curcumin, the main polyphenolic curcuminoid in turmeric, contains antioxidant, anticarcinogenic, anti-HIV, antibacterial, and anti-inflammatory properties [14].

According to several studies from the past ten years, combining naturally occurring compounds produced from plants with widely used antibiotics may represent a new approach that might be utilized to defeat bacteria that are resistant to several antibiotics. Promising natural antimicrobial agents are plant-derived polyphenols, which have been demonstrated to exhibit antibacterial activity and to make antibiotics more effective against multidrug-resistant strains [15]. Few studies have shown the effect of RSV on the gene expression of MRSA enterotoxins and PV-leukocidins. Moreover, the effect of CUR on gene expression in MRSA was not discussed in any of the previous studies. In this research, we sought to examine the impact of RSV and CUR, two naturally occurring polyphenolic compounds, on the toxin production by MRSA isolates.

Materials and Methods

Bacterial Strains and Reagents

A total of 50 MRSA isolates were acquired from KAIMARC, Riyadh, and Jeddah, Kingdom of Saudi Arabia (KSA). They were obtained from various clinical samples of the following origin: respiratory, wound, tissue, eye swab, bone sterile, aspiration fluid, bed swab, ear, nasal swab, and groin. The VITEK 2 system (bioMerieux, France) and S. aureus (Baa977) as a reference strain were used to identify and confirm that each isolate was MRSA. Confirmed isolates were kept at −80°C for further studies.

RSV (cat. no. 501-36-0, Hi-Tech Development Zone, Xi’an, China) and CUR (cat. no. 458-37-7, AK Scientific, USA) were used for the preparation of stock solutions (12 mg/ml) in dimethyl sulfoxide (DMSO) (Merck, Sigma Aldrich, USA). The working solutions were prepared just before each experiment. Negative-control cultures received an equivalent amount of DMSO. This research was approved by the Institutional Review Board, Princess Nourah bint Abdulrahman University.

Determination of Minimum Inhibitory Concentration (MIC) of RSV and CUR

The procedures of the Clinical Laboratory Standards Institute (CLSI) were followed with minor modifications to estimate the MIC of RSV and CUR against MRSA isolates [16]. RSV and CUR were diluted two-fold serially (2000 to 15.6 g/ml) and added to overnight cultures of strains in Brain Heart Infusion (BHI) broth (HiMedia, India) that were adjusted to an optical density at 600 nm of 0.08 to 0.1 in a 96-well microtiter plate. The lowest concentration at which the organism shows no discernible growth was determined to be the MIC after incubation at 37°C. All experiments were done in triplicate.

Effect of Sub-MIC on the Viability of MRSA

To ascertain the effects of RSV (100 and 50 μg/ml) and CUR (50 and 20 μg/ml) sub-MICs on MRSA growth, viable count experiment using pour plate method was performed [17]. The number of surviving cells of MRSA isolates treated with sub-MICs of RSV and CUR was compared with the untreated cells cultivated under the same conditions.

Molecular Characterization of Toxin-Encoding Genes

All MRSA strains had their genomic DNA extracted using a DNA Mini Extraction Kit (Qiagen, Germany) according to the manufacturer's instructions.

The existence of several toxin genes (sea, seb, sec, sed, seh, lukF, and lukS) [18] [19] was investigated using uniplex PCR amplifications. Table 1 lists sets of primers used in this study. A thermocycler machine (Cleaver Scientific Ltd., GTC96S, UK) was used to carry out the amplifications. For each primer, the PCR was run under predetermined temperature profile and PCR conditions [18, 19]. The PCR products were examined on 1.2%agarose gel (GIBCO Bethesda Research Lab, Life Technology, USA) stained with ethidium bromide (Sigma No. E7637), compared with 100 bp plus DNA ladder (Thermo Fisher Scientific, USA) and scanned using a gel documentation and analysis system (Gel DocTM XR+, Bio-Rad, USA). Strains that produced the PCR products were used for further experiments.

Table 1.

Primer sequences of the tested genes.

Gene Sequence Amplicon size Reference
sea F 5'-AGCTTGTATGTATGGTGGTGT-3'
R 5'-ACGTCTTGCTTGAAGATCCA-3'
172 [18]
seb F 5'-AGGACACTAAGTTAGGGAAT-3'
R 5'-CTCAGTTACACCACCATACA-3'
200 [18]
sec F 5'-TGTAGGTAAAGTTACAGGTGGT-3'
R 5'-TGTCTAGTTCTTGAGCTGTTAC-3'
182 [18]
sed F 5'-GTTTGATTCTTCTGATGGGTCT-3'
R 5-GAAGGTGCTCTGTGGATAATG-3'
119 [18]
seh F 5'-TGCGAAAGCAGAAGATTTACAC-3'
R 5'-TCATTGCCACTATCACCTTGA-3
165 [18]
lukF F 5'-TGTGCTTCTACTTTCCACCAT-3'
R 5'-TGTGACTGACTTTTGCACCA-3'
225 [19]
lukS F 5'-GGTCCATCAACAGGAGGTAAT-3'
R 5'-AGGATTGAAACCACTGTGTACT-3'
267 [19]
nuc F 5'-GCGATTGATGGTGATACGGTI-3'
R 5'AGCCAAGCCTTGACGAACTAAAGC-3'
267 [20]

F, forward; R, reverse

Quantitative Real-Time PCR

Stored bacterial isolates were subcultured on BHI agar at 37°C for 18–24 h. For each isolate, 3 bacterial suspensions were prepared and adjusted to 0.5 MacFarland in 3 tubes; one of them was used as the control (C) without the phenolic compound and the other two tubes (T) were treated with the chosen sub-MIC of RSV (50 μg/ml) and CUR (20 μg/ml). The (C) and (T) tubes were incubated overnight on a shaker incubator at 37°C and 150 rpm and centrifuged before mechanical disruption. TRI Reagent (T9424 Sigma-Aldrich, USA) was used to extract the total RNA. RNA concentration and purity were calculated using a Nanodrop-1000 Spectrophotometer (USA). The RNA integrity was confirmed by gel electrophoresis using 2% agarose gel loaded with 5 μl of the total RNA.

The High-Capacity cDNA Reverse Transcription Kit (cat. no. 4368814, Thermo Fisher) was used to reverse-transcribe whole RNA according to the manufacturer's instructions. The cDNA was stored at -20°C.

Using the previously described primers, RT-PCR was used to determine the expression level of the sea, seb, LukF, and LukS genes. nuc gene served as an internal MRSA housekeeping gene [20]. To prepare the reaction mixture, HOT FIREPol SolisGreen qPCR Mix (5X, cat. no. 08-46-0000S) was used; and the program was run as follows: PCR initial activation step for 10 min at 95°C, denaturation for 30 s at 95°C, annealing for 30 s at suitable annealing temperature for each primer, and extension at 72°C for 30 s. Reactions were run for 45 cycles using Quantstudio 5 (Applied Biosystems, Thermo Fischer).

Melting curve analysis of the PCR product(s) to verify their specificity and identity was performed and the 2−ΔΔCT method was used to calculate the normalized relative expression.

Statistical Analysis

GraphPad Prism 5 by Dotmatics was used to analyze the results. The treated isolates were compared with the control group using one-way analysis of variance (ANOVA) and Dunnett's posttest for multiple comparisons. Statistical significance was defined as a p-value of 0.05 or less.

Results

Determination of MIC and the Effect of Sub-MICs of Resveratrol and Curcumin on the Viability of MRSA Strains

To calculate the impact of their sub-MICs on bacterial growth and toxin expression, the microbroth dilution method was used to determine the MICs of both RSV and CUR. The MICs were found to be 500 and 125 μg/ml, respectively, for all the tested isolates for RSV and CUR. When cultured with 50 μg/ml RSV and 20 μg/ml CUR, all isolates exhibited nearly the same bacterial count (158 × 108 CFU/ml) compared to that of the untreated cultures (162 × 108 CFU/ml). Therefore, in further experiments, concentrations of 50 and 20 μg/ml of RSV and CUR, respectively, were used to assess the virulence factors of MRSA isolates.

Molecular Screening of Various Toxin Genes Among MRSA Strains

Fig. 1 represented the molecular detection of toxin genes (sea, seb, sec, sed, seh, lukF, and lukS) that was performed by uniplex PCR. lukF gene was found in 44 strains (88%) with equal distribution between strains from Riyadh and Jeddah (22 isolates from both harbored lukF gene). The distribution of other toxin genes was as follows: lukS gene was detected in 14 strains (28%), followed by sea gene in 13 strains (26%), seb in 7 strains (14%), seh in 5 strains (10%), sec in 4 strains (8%), and sed in only 2 strains (4%), as shown in Fig. 2. Table 2 displays the 11 toxin gene patterns that were identified through examination of the PCR results. Five toxicity patterns were exhibited by strains isolated from Riyadh and Jeddah (P1-P4 and P11). Five toxicity patterns were found in the Riyadh isolates and only one toxicity pattern was found in the Jeddah isolates. Six isolates were not harboring any of the toxin genes. Isolates from Riyadh were found to have the highest toxin gene patterns, and for this reason they were used for quantitative real-time PCR.

Fig. 1. PCR for toxin genes in MRSA isolates.

Fig. 1

(A) Isolate No. 2: Lane (1) sea, Lane (2): seb. (B) Lane (1) sec (Isolate No. 7), Lane (2): sed (Isolate No. 17), Lane (3): she (Isolate No. 10). (C) Isolate No. 4: Lane (3) lukF, Lane (6): lukS. Lane (M): 100 bp plus DNA ladder.

Fig. 2. Distribution of toxin genes among MRSA strains acquired from KAIMARC, Riyadh and Jeddah, KSA.

Fig. 2

Table 2.

Toxin gene patterns identified among MRSA isolates.

Pattern No. Toxin profile Riyadh isolates Jeddah isolates Total p-value
P1 lukF-PV 4 9 13 0.1854
P2 lukF-PV, lukS-PV 2 4 6 0.6640
P3 sea, lukF-PV 2 3 5 1.0000
P4 seb, lukF-PV 4 2 6 0.6640
P5 sea, sec, lukF-PV 2 0 2 0.4884
P6 sea, sed, lukF-PV 2 0 2 0.4884
P7 sea, seh, lukF-PV 1 0 1 1.0000
P8 sea, lukF-PV, lukS-PV 3 0 3 0.2326
P9 seb, seh, lukF-PV 1 0 1 1.0000
P10 sec, lukF-PV, lukS-PV 0 2 2 0.4884
P11 seh, lukF-PV, lukS-PV 1 2 3 1.0000
22 22 44

Real-Time PCR for Determination of Relative Gene Expression of Toxin Genes

The relative gene expression using real-time PCR of lukF, lukS, sea, and seb genes was performed due to their higher frequency among the tested isolates. Fig. 3 demonstrated the relative expression levels of the sea gene in 5 positive sea MRSA strains (2, 7, 10, 17, and 21) treated with RSV (50 μg/ml) and CUR (20 μg/ml). It was revealed that among the tested isolates, RSV dramatically decreased the transcription of the sea gene by 85–99.9%. In addition, CUR downregulated the level of transcription of the sea gene in all tested isolates by 43–99.9%.

Fig. 3. Effect of RSV (R) and CUR (C) on relative gene expression of sea gene in sea positive MRSA isolates (2, 7, 10, 17, 21).

Fig. 3

The effect of each concentration is compared to untreated control.

Both RSV (50 μg/ml) and CUR (20 μg/ml) decreased the expression of seb gene with different degrees on the tested MRSA strains. RSV reduced the seb expression by 90–99.6%. CUR downregulated the transcription with 94.5% in strain No. 2, while the reduction was only 10% in strain No. 8 as shown in Fig. 4.

Fig. 4. Effect of RSV (R) and CUR (C) on relative gene expression of seb gene in seb positive MRSA isolates (2, 8).

Fig. 4

The effect of each concentration is compared to untreated control.

The relative expression levels of lukF gene of 8 positive lukF MRSA isolates (2, 4, 7, 10, 15, 17, 22, 41) after incubation with RSV and CUR was monitored. Fig. 5 showed that RSV significantly reduced the transcription of lukF gene among the tested isolates ranging from 1.7–99.8%, while CUR upregulated the level of transcription of lukF gene in all tested isolates except isolates 10 and 15, in which CUR downregulated the transcription by 9.3%and 23% respectively.

Fig. 5. Effect of RSV (R) and CUR (C) on relative gene expression of lukF gene in lukF positive MRSA isolates (2, 4, 7, 10, 15, 17, 22, 41).

Fig. 5

The effect of each concentration is compared to untreated control.

Fig. 6 showed that RSV significantly downregulated the gene expression of lukS gene in the five tested isolates by 95–100%. CUR decreased gene expression only in isolate 21, while upregulating the expression in the other tested isolates.

Fig. 6. Effect of RSV (R) and CUR (C) on relative gene expression of lukS gene in lukS positive MRSA isolates (4, 15, 21, 25, 41).

Fig. 6

The effect of each concentration is compared to untreated control.

Discussion

Staphylococcus aureus is one of the main bacterial infections that affect humans and cause a wide range of clinical symptoms. Due to the rise of multi-drug resistance strains like MRSA, infections are widespread in both community- and hospital-acquired settings, and treatment is still challenging to manage. Most healthy people have S. aureus on their skin and mucous membranes, usually in the nose region. S. aureus is also present in the environment and in typical human flora. Normal healthy skin does not become infected by S. aureus; but, if the germs are permitted to penetrate the bloodstream or internal tissues, they may cause a number of potentially harmful illnesses. Direct contact is usually how transmission occurs, while other means of transmission cause various other illnesses. The prevalence of virulent, drug-resistant MRSA strains has exacerbated the morbidity and mortality brought on by S. aureus infection [21]. On the one hand, it is believed that S. aureus may be able to create a chronic infection through the secretion of a large quantity of toxins [22].

Because of their therapeutic properties, plant-derived compounds have been used to treat a wide range of human diseases. Polyphenolic chemicals obtained from several plant sources, including flavonoids and phenolic acids, show antimicrobial activity against a diversity of microorganisms, and provide useful antibacterial tools for natural warfare [23].

RSV a polyphenolic substance found in numerous plant extracts, possesses a range of biological activities, including anti-inflammatory, anti-cancer, and antibacterial actions [24]. Several studies suggest that RSV inhibits the expression of toxins [25]. RSV inhibits the endocytosis of the cholera toxin (CT) into host cells for Vibrio cholerae and specifically binds CT, potentially preventing the diarrhea that CT causes [26]. Consequently, RSV greatly lowers S. aureus in human blood cells [27].

Curcumin, which gives turmeric its yellow color, is also a polyphenolic compound. Multiple pharmacological properties of CUR have been reported including antimicrobial, antidiabetic, anti-inflammatory, anticancer, and antioxidant properties [28]. The first studies on CUR biological action were based on its antibacterial activity against S. aureus, Trichophyton gypseum, Salmonella paratyphi, and Mycobacterium tuberculosis [29]. Curcumin's ability to combat MSSA and MRSA has been established in recent years [30]. Curcumin decreases the development of bacterial biofilms, host receptor attachment, and other virulence factors by bacteria thanks to their quorum sensing regulatory mechanism [31].

This is the first investigation into how RSV and CUR affect the expression of several S. aureus toxins in Saudi Arabia. Our results showed that RSV and CUR have the ability to downregulate the toxin production at sub-MICs of RSV (50 μg/ml) and CUR (20 μg/ml). Such attributes may be important in reducing the virulence of MRSA strains and could be used to combat the resistance of MRSA to antibiotics, either if those natural compounds are used alone or in combination with antibiotics.

Numerous human cases of food poisoning and infections of the soft tissues and bones, as well as potentially fatal toxic shock, are caused by S. aureus. Staphylococcal enterotoxins (SEs) are among the virulence factors that are produced by this ubiquitous bacterium. Along with the SEs that activate particular T cell subsets [32], other virulence factors secreted by S. aureus include adhesins, collagenases, protein A, coagulases, hemolysins, and leukocidins [33]. MRSA's pathogenicity is increased by the leukotoxin Panton-Valentine leukocidin (PVL), which can also result in severe necrotic pneumonia. PVL is coded by the toxins lukS-PV and lukF-PV [34].

Many phenolic substances and extracts can block the synthesis and/or action of bacterial enterotoxins, even at concentrations below the MIC [35]. These phenolic substances can influence the production of enterotoxins in a variety of ways, including by inhibiting translation and/or transcription, disabling secretory pathways, impairing quorum sensing regulatory systems, and toxin inactivation [36].

Resveratrol and curcumin were effective against the tested MRSA isolates in this study with MICs of 500 and 125 μg /ml, respectively. The results regarding RSV’s MIC are in line with those of Duan et al. [22], who claimed that the compound's MIC value against four strains of different ST-type S. aureus strains was 512 μg/ml. According to Su et al. [37], the RSV’s MIC range for each of the 34 used strains obtained from blood was 500–1,000 μg/ml. A study using 10 isolates of S. aureus obtained from Wonkwang University Hospital and from the Culture Collection of Antimicrobial Resistant Microbes (CCARM) revealed that the MIC of CUR ranged from 125 to 250 μg/ml [38]. In agreement with our results, Kali et al. [39] found that the CUR MIC against 15 gram-positive bacteria, including two Enterococcus faecalis and thirteen S. aureus strains, was 126.9 μg/ml.

Screening of MRSA toxin genes was done using uniplex PCR for detection of sea, Seb, sec, sed, seh, lukF, and lukS genes. The results revealed that the most predominant gene among the tested genes was lukF gene that was found in 44 (88%) of isolates with equal distribution between the Riyadh and Jeddah isolates. The least gene detected was sed gene detected only in 2 (4%) strains as shown in Fig. 1. The profile of toxin genes was done based on analysis of PCR results; we investigated 11 toxin gene patterns as illustrated in Table 1. Five patterns were common for strains isolated from Riyadh and Jeddah (P1-P4 and P11). The Riyadh isolates exhibited five toxicity patterns, while only one toxicity pattern was found in the Jeddah isolates.

Resveratrol and curcumin were used in sub-MIC concentrations (50 and 20 μg/ml, respectively) to determine their effect on the relative expression levels of toxin genes. Regarding enterotoxin genes sea and seb, the inhibitory effect of RSV on both genes was significant among the tested isolates and ranged from 85–99.9% for sea gene and from 90–99.6% for seb gene. Curcumin downregulated the level of transcription of the sea gene in all tested isolates from 43–99.9%, while for seb gene, CUR downregulated the transcription of the two tested stains with 94.5% in strain No. 2 and only 10% is strain No. 8. Our findings are consistent with those of Shimamura et al. [40], who claimed that RSV significantly reduced the expression of the sea gene in S. aureus C-29. According to Kadhim et al.[41], RSV treatment reversed all inflammatory markers, and liver damage caused by seb was reduced significantly. These findings support earlier research indicating that RSV is a strong anti-inflammatory drug that can shield mice from acute lung injury caused by seb [42]. Bisdemethoxycurcumin (BDMC), an analogue of CUR, was studied by Wang et al. [43] for its ability to suppress the MRSA enterotoxins A and B. In S. aureus ATCC 33591, the transcription levels of both sea and seb decreased by 1.7-fold and 5-fold, respectively, leading to a dose-dependent substantial downregulation of the expression of both proteins.

The effect of RSV and CUR on leukocidin genes was also studied, and the results showed that CUR significantly increased the expression of both lukF and lukS genes in the majority of tested isolates, while RSV significantly decreased the expression of both genes in those isolates. Due to its impact on leukocytes and resistance to phagocytosis, the capacity of RSV to lower lukF/S gene expression is a crucial property that helps the pathogen survive longer in tissues during infections. Previous studies only described the effect of RSV on the gene expression of the hly gene, therefore the effect of those two compounds on the gene expression of PV genes was explored for the first time [22].

We conclude that RSV and CUR, two naturally occurring substances derived from plants, exhibit an inhibitory effect on the gene expression of MRSA toxin at sub-MIC levels. Resveratrol inhibited gene expression of the tested toxin genes by downregulating their transcription, while CUR showed less effect on the gene expression of the tested genes. More work is needed to study the effect of CUR on toxin production. Finally, the results revealed that both compounds could be used as candidate drugs for the treatment of MRSA infections as an innovative, therapeutic approach.

Acknowledgements

This research was funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2024R166), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Footnotes

Ethics Declarations

This research was approved by the Institutional Review Board, Princess Nourah bint Abdulrahman University (IRB Log Number: 20-0488).

Author Contributions

AME, and SHA conceived the study, designed experiments, and analyzed data. AME, MA, and SHA performed experiments and/or analyzed data. AME, and SHA wrote the manuscript. All authors reviewed and commented on the final version of the manuscript.

Conflict of Interest

The authors have no financial conflicts of interest to declare.

References

  • 1.DeLeo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect. Dis. Clin. North Am. 2009;23:17–34. doi: 10.1016/j.idc.2008.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG., Jr Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015;28:603–661. doi: 10.1128/CMR.00134-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Okwu MU, Olley M, Akpoka AO, Izevbuwa OE. Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: a brief review. AIMS Microbiol. 2019;5:117–137. doi: 10.3934/microbiol.2019.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat. Rev. Microbiol. 2019;17:203–218. doi: 10.1038/s41579-018-0147-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Grumann D, Nübel U, Bröker BM. Staphylococcus aureus toxins-their functions and genetics. Infect. Genet. Evol. 2014;21:583–592. doi: 10.1016/j.meegid.2013.03.013. [DOI] [PubMed] [Google Scholar]
  • 6.Oliveira D, Borges A, Simoes M. Staphylococcus aureus toxins and their molecular activity in infectious diseases. Toxins (Basel) 2018;10:252. doi: 10.3390/toxins10060252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bukowski M, Wladyka B, Dubin G. Exfoliative toxins of Staphylococcus aureus. Toxins (Basel) 2010;2:1148–1165. doi: 10.3390/toxins2051148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nishifuji K, Sugai M, Amagai M. Staphylococcal exfoliative toxins:"molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J. Dermatol. Sci. 2008;49:21–31. doi: 10.1016/j.jdermsci.2007.05.007. [DOI] [PubMed] [Google Scholar]
  • 9.Wilson GJ, Seo KS, Cartwright RA, Connelley T, Chuang-Smith ON, Merriman JA, et al. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog. 2011;7:e1002271. doi: 10.1371/journal.ppat.1002271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Miklasińska-Majdanik M, Kępa M, Wojtyczka RD, Idzik D, Wąsik TJ. Phenolic compounds diminish antibiotic resistance of Staphylococcus aureus clinical strains. Int. J. Environ. Rre. Public Health. 2018;15:2321. doi: 10.3390/ijerph15102321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dong Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat. Res. 2003;523:145–150. doi: 10.1016/S0027-5107(02)00330-5. [DOI] [PubMed] [Google Scholar]
  • 12.Sun Q, Heilmann J, Konig B. Natural phenolic metabolites with anti-angiogenic properties - a review from the chemical point of view. Beilstein J. Org. Chem. 2015;11:249–264. doi: 10.3762/bjoc.11.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sadruddin S, Arora R. Resveratrol: biologic and therapeutic implications. J. Cardiometab. Syndr. 2009;4:102–106. doi: 10.1111/j.1559-4572.2008.00039.x. [DOI] [PubMed] [Google Scholar]
  • 14.Smitha S, Dhananjaya BL, Dinesha R, Srinivas L. Purification and characterization of a approximately 34 kDa antioxidant protein (beta-turmerin) from turmeric (Curcuma longa) waste grits. Biochimie. 2009;91:1156–1162. doi: 10.1016/j.biochi.2009.06.006. [DOI] [PubMed] [Google Scholar]
  • 15.Zacchino SA, Butassi E, Liberto MD, Raimondi M, Postigo A, Sortino M. Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs. Phytomedicine. 2017;37:27–48. doi: 10.1016/j.phymed.2017.10.018. [DOI] [PubMed] [Google Scholar]
  • 16.Humphries RM, Ambler J, Mitchell SL, Castanheira M, Dingle T, Hindler JA, et al. CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. J. Clin. Microbiol. 2018;56:10.1128/jcm.01934-01917. doi: 10.1128/JCM.01934-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Standards Australia, author. Water Microbiology-Heterotrophic Colony Count Methods-Pour Plate Method using Plate Count Agar. AS 4276.3.1. Committee FT/20 WMHb. Australia: Council of Standards Australia; 1995. [Google Scholar]
  • 18.Rehab ME, Dina ER, Shaymaa H. Toxin gene profile and antibiotic resistance of Staphylococcus aureus isolated from clinical and food samples in Egypt. Afr. J. Microbiol Res. 2016;10:428–437. doi: 10.5897/AJMR2015.7927. [DOI] [Google Scholar]
  • 19.Abdel-hamed A-HA, Abdel-Rhman SH, El-Sokkary MA. Studies on leukocidins toxins and antimicrobial resistance in Staphylococcus aureus isolated from various clinical sources. Afr. J. Microbiol. Res. 2016;10:591–599. doi: 10.5897/AJMR2015.7892. [DOI] [Google Scholar]
  • 20.Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 1992;30:1654–1660. doi: 10.1128/jcm.30.7.1654-1660.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Shimamura Y, Utsumi M, Hirai C, Nakano S, Ito S, Tsuji A, et al. Binding of catechins to staphylococcal enterotoxin A. Molecules. 2018;23:1125. doi: 10.3390/molecules23051125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Duan J, Li M, Hao Z, Shen X, Liu L, Jin Y, et al. Subinhibitory concentrations of resveratrol reduce alpha-hemolysin production in Staphylococcus aureus isolates by downregulating saeRS. Emerg. Microbes Infect. 2018;7:136. doi: 10.1038/s41426-018-0142-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zacchino SA, Butassi E, Di Liberto M, Raimondi M, Postigo A, Sortino M. Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs. Phytomedicine. 2017;37:27–48. doi: 10.1016/j.phymed.2017.10.018. [DOI] [PubMed] [Google Scholar]
  • 24.Vasavi H, Sudeep H, Lingaraju H, Prasad KS. Bioavailability-enhanced Resveramax™ modulates quorum sensing and inhibits biofilm formation in Pseudomonas aeruginosa PAO1. Microb. Pathog. 2017;104:64–71. doi: 10.1016/j.micpath.2017.01.015. [DOI] [PubMed] [Google Scholar]
  • 25.Santhakumari S, Ravi A. Targeting quorum sensing mechanism: an alternative anti-virulent strategy for the treatment of bacterial infections. S. Afr. J. Bot. 2019;120:81–86. doi: 10.1016/j.sajb.2018.09.028. [DOI] [Google Scholar]
  • 26.Cherubin P, Garcia MC, Curtis D, Britt CB, Craft JW, Jr, Burress H, et al. Inhibition of cholera toxin and other AB toxins by polyphenolic compounds. PLoS One. 2016;11:e0166477. doi: 10.1371/journal.pone.0166477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ma DS, Tan LTH, Chan KG, Yap WH, Pusparajah P, Chuah LH, et al. Resveratrol-potential antibacterial agent against foodborne pathogens. Front. Pharmacol. 2018;9:102. doi: 10.3389/fphar.2018.00102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zorofchian Moghadamtousi S, Abdul Kadir H, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res. Int. 2014;2014:186864. doi: 10.1155/2014/186864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Schraufstätter E, Bernt H. Antibacterial action of curcumin and related compounds. Nature. 1949;164:456–457. doi: 10.1038/164456a0. [DOI] [PubMed] [Google Scholar]
  • 30.Wang J, Zhou X, Li W, Deng X, Deng Y, Niu X. Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin. Sci. Rep. 2016;6:28254. doi: 10.1038/srep28254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zheng D, Huang C, Huang H, Zhao Y, Khan MRU, Zhao H, et al. Antibacterial mechanism of curcumin: a review. Chem. Biodivers. 2020;17:e2000171. doi: 10.1002/cbdv.202000171. [DOI] [PubMed] [Google Scholar]
  • 32.Fraser JD, Proft T. The bacterial superantigen and superantigen‐like proteins. Immunol. Rev. 2008;225:226–243. doi: 10.1111/j.1600-065X.2008.00681.x. [DOI] [PubMed] [Google Scholar]
  • 33.Thurlow LR, Joshi GS, Richardson AR. Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) FEMS Immunol. Med. Microbiol. 2012;65:5–22. doi: 10.1111/j.1574-695X.2012.00937.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.van der Meeren BT, Millard PS, Scacchetti M, Hermans MH, Hilbink M, Concelho TB, et al. Emergence of methicillin resistance and P anton‐V alentine leukocidin positivity in hospital‐and community‐acquired Staphylococcus aureus infections in B eira, M ozambique. Trop. Med. Int. Health. 2014;19:169–176. doi: 10.1111/tmi.12221. [DOI] [PubMed] [Google Scholar]
  • 35.Muñoz-Cazares N, García-Contreras R, Pérez-López M, Castillo-Juárez I. Phenolic compounds with anti-virulence properties. Phenolic Compounds-Biological Activity; 2017. pp. 139–167. [Google Scholar]
  • 36.Rasooly R, Molnar A, Choi H-Y, Do P, Racicot K, Apostolidis E. In-vitro inhibition of staphylococcal pathogenesis by witchhazel and green tea extracts. Antibiotics. 2019;8:244. doi: 10.3390/antibiotics8040244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Su Y, Ma L, Wen Y, Wang H, Zhang S. Studies of the in vitro antibacterial activities of several polyphenols against clinical isolates of methicillin-resistant Staphylococcus aureus. Molecules. 2014;19:12630–12639. doi: 10.3390/molecules190812630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Mun SH, Joung DK, Kim YS, Kang OH, Kim SB, Seo YS, et al. Synergistic antibacterial effect of curcumin against methicillinresistant Staphylococcus aureus. Phytomedicine. 2013;20:714–718. doi: 10.1016/j.phymed.2013.02.006. [DOI] [PubMed] [Google Scholar]
  • 39.Kali A, Bhuvaneshwar D, Charles PM, Seetha KS. Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates. J. Basic Clin. Pharm. 2016;7:93. doi: 10.4103/0976-0105.183265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Shimamura Y, Hirai C, Sugiyama Y, Shibata M, Ozaki J, Murata M, et al. Inhibitory effects of food additives derived from polyphenols on staphylococcal enterotoxin A production and biofilm formation by Staphylococcus aureus. Biosci. Biotechnol. Biochem. 2017;81:2346–2352. doi: 10.1080/09168451.2017.1395681. [DOI] [PubMed] [Google Scholar]
  • 41.Kadhim S, Singh NP, Zumbrun EE, Cui T, Chatterjee S, Hofseth L, et al. Resveratrol-mediated attenuation of Staphylococcus aureus enterotoxin b-induced acute liver injury is associated with regulation of microrna and induction of myeloid-derived suppressor cells. Front. Microbiol. 2018;9:2910. doi: 10.3389/fmicb.2018.02910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Alghetaa H, Mohammed A, Sultan M, Busbee P, Murphy A, Chatterjee S, et al. Resveratrol protects mice against SEB‐induced acute lung injury and mortality by miR‐193a modulation that targets TGF‐β signalling. J. Cell. Mol. Med. 2018;22:2644–2655. doi: 10.1111/jcmm.13542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Wang S, Kang OH, Kwon DY. Bisdemethoxycurcumin reduces methicillin-resistant Staphylococcus aureus expression of virulence-related exoproteins and inhibits the biofilm formation. Toxins. 2021;13:804. doi: 10.3390/toxins13110804. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Microbiology and Biotechnology are provided here courtesy of Korean Society for Microbiology and Biotechnology

RESOURCES